{"id":"NCT02495168","sponsor":"Actavis Inc.","briefTitle":"Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants","officialTitle":"A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter, Multinational Study to Compare the Therapeutic Equivalence of a Budesonide 80 μg/Formoterol Fumarate Dihydrate 4.5 μg Inhalation Aerosol (Manufactured by Catalent for Watson Laboratories Inc.) to Symbicort® (Budesonide 80 μg/Formoterol Fumarate Dihydrate 4.5 μg Inhalation Aerosol) (Manufactured by AstraZeneca) in Adolescent and Adult Patients With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-13","primaryCompletion":"2018-05-31","completion":"2018-05-31","firstPosted":"2015-07-13","resultsPosted":"2019-11-29","lastUpdate":"2019-11-29"},"enrollment":1714,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Generic Budesonide/Formoterol Fumarate Dihydrate","otherNames":[]},{"type":"DRUG","name":"Symbicort® (Budesonide/Formoterol Fumarate Dihydrate)","otherNames":["Symbicort Turbohaler®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Generic Budesonide/Formoterol Fumarate Dihydrate","type":"EXPERIMENTAL"},{"label":"Symbicort (Budesonide/Formoterol Fumarate Dihydrate)","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study has a randomized multiple-dose, placebo-controlled, parallel group design consisting of a 2-week open placebo Run-in Period followed by a 6-week Treatment Period with placebo, test product (budesonide 80 microgram \\[μg\\]/formoterol fumarate dihydrate 4.5 μg), or reference product (Symbicort® inhalation aerosol).","primaryOutcome":{"measure":"Equivalence Analysis of Area Under the Serial FEV1-Time Effect Curve From Time 0 to 12 Hours (FEV1 Area Under Curve [AUC0-12]) on the First Day of Treatment","timeFrame":"0 to 12 hours on Day 1","effectByArm":[{"arm":"Generic Budesonide/Formoterol Fumarate Dihydrate","deltaMin":3.637,"sd":3.2532},{"arm":"Symbicort (Budesonide/Formoterol Fumarate Dihydrate)","deltaMin":3.584,"sd":2.9913},{"arm":"Placebo","deltaMin":1.46,"sd":3.3183}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":17,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":501},"commonTop":["Upper respiratory tract infection","Headache","Viral upper respiratory tract infection","Asthma","Dysphonia"]}}